UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer

Frontiers in oncology, 2021-12, Vol.11, p.788875-788875

2021

Volltextzugriff (PDF)

Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment

Cancer Immunology, Immunotherapy, 2019-10, Vol.68 (10), p.1635-1648

2019

Volltextzugriff (PDF)

Role of an anti-gastrin vaccine (PAS) alone and in combination with a PD-1 antibody on growth and metastases of gastric cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.334-334

2022

Volltextzugriff (PDF)

Abstract 109: Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse model

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.109-109

2021

Volltextzugriff (PDF)

Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model

Cancer prevention research (Philadelphia, Pa.), 2021-10, Vol.14 (10), p.933-944

2021

Volltextzugriff (PDF)

Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment

Cancer Immunology, Immunotherapy, 2019-10, Vol.68 (10), p.1635-1648

2019

Volltextzugriff (PDF)

Use of gastrin vaccine to increase gamma-delta and NKT cells and alter pancreas tumor microenvironment to improve survival

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.696-696

2020

Volltextzugriff (PDF)

Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases

American journal of physiology: Gastrointestinal and liver physiology, 2019-11, Vol.317 (5), p.G682-G693

2019

Volltextzugriff (PDF)

Gastrin vaccine and immune checkpoint antibody therapy for pancreatic cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.259-259

2019

Volltextzugriff (PDF)

Effect of Renal Impairment on the Pharmacokinetics and Tolerability of Tiagabine

Epilepsia (Copenhagen), 1998-01, Vol.39 (1), p.43-47

1998

Volltextzugriff (PDF)

Multidose Pharmacokinetics of Ritonavir and Zidovudine in Human Immunodeficiency Virus-Infected Patients

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1788-1793

1998

Volltextzugriff (PDF)

A Placebo-Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non-Benzodiazepine Hypnotic

Journal of clinical pharmacology, 1994-04, Vol.34 (4), p.335-344

1994

Volltextzugriff (PDF)

Evaluation of the effect of fluconazole on the pharmacokinetics of ritonavir

Drug metabolism and disposition, 1997-09, Vol.25 (9), p.1104

1997

Volltextzugriff (PDF)

Initial Clinical Trial of a High-affinity Retinoic Acid Receptor Ligand (LGD1550)

Clinical cancer research, 2000-05, Vol.6 (5), p.1731

2000

Volltextzugriff (PDF)

The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin

Clinical pharmacology and therapeutics, 1998-04, Vol.63 (4), p.414-421

1998

Volltextzugriff (PDF)

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

The New England journal of medicine, 1981-04, Vol.304 (16), p.934

1981

Volltextzugriff (PDF)

Age-Related Changes in Valproic Acid Binding to Rat Serum Proteins in Vitro

Journal of pharmaceutical sciences, 1996-04, Vol.85 (4), p.373-376

1996

Volltextzugriff (PDF)

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: A prospective, double-blind, randomized, controlled trial

Critical care medicine, 1995-01, Vol.23 (1), p.9-17

1995

Volltextzugriff (PDF)

A clinical study to determine the efficacy and safety of 1% methotrexate/Azone® (MAZ) gel applied topically once daily in patients with psoriasis vulgaris

International journal of dermatology, 2001-07, Vol.40 (7), p.464-467

2001

Volltextzugriff (PDF)

Azone® enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis

International journal of dermatology, 2001-03, Vol.40 (3), p.232-236

2001

Volltextzugriff (PDF)

Rationale and Proposal for Use of Prostacyclin in Thrombotic Thrombocytopenic Purpura Therapy

Seminars in thrombosis and hemostasis, 1981, Vol.7 (1), p.43-51

1981

Volltextzugriff (PDF)

Ineffective epoprostenol therapy for thrombotic thrombocytopenic purpura

JAMA : the journal of the American Medical Association, 1983-12, Vol.250 (22), p.3089

1983

Volltextzugriff (PDF)

Effects of prostacyclin infusion in uremic patients: Hematologic and hemodynamic responses

Clinical pharmacology and therapeutics, 1981-08, Vol.30 (2), p.251-257

1981

Volltextzugriff (PDF)

Age-dependent intestinal absorption of valproic acid in the rat

Pharmaceutical research, 1995-02, Vol.12 (2), p.284-290

1995

Volltextzugriff (PDF)

Activity of a triamcinolone acetonide/laurocapram formulation: double-blind comparisons with triamcinolone acetonide, placebo vehicle, and mid-strength (Class IV) to potent (Class II) corticosteroids

Current therapeutic research, 2001-03, Vol.62 (3), p.180-186

2001

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(68)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer

Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment

Role of an anti-gastrin vaccine (PAS) alone and in combination with a PD-1 antibody on growth and metastases of gastric cancer

Abstract 109: Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse model

Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model

Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment

Use of gastrin vaccine to increase gamma-delta and NKT cells and alter pancreas tumor microenvironment to improve survival

Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases

Gastrin vaccine and immune checkpoint antibody therapy for pancreatic cancer

Effect of Renal Impairment on the Pharmacokinetics and Tolerability of Tiagabine

Multidose Pharmacokinetics of Ritonavir and Zidovudine in Human Immunodeficiency Virus-Infected Patients

A Placebo-Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non-Benzodiazepine Hypnotic

Evaluation of the effect of fluconazole on the pharmacokinetics of ritonavir

Initial Clinical Trial of a High-affinity Retinoic Acid Receptor Ligand (LGD1550)

The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

Age-Related Changes in Valproic Acid Binding to Rat Serum Proteins in Vitro

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: A prospective, double-blind, randomized, controlled trial

A clinical study to determine the efficacy and safety of 1% methotrexate/Azone® (MAZ) gel applied topically once daily in patients with psoriasis vulgaris

Azone® enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis

Rationale and Proposal for Use of Prostacyclin in Thrombotic Thrombocytopenic Purpura Therapy

Ineffective epoprostenol therapy for thrombotic thrombocytopenic purpura

Effects of prostacyclin infusion in uremic patients: Hematologic and hemodynamic responses

Age-dependent intestinal absorption of valproic acid in the rat

Activity of a triamcinolone acetonide/laurocapram formulation: double-blind comparisons with triamcinolone acetonide, placebo vehicle, and mid-strength (Class IV) to potent (Class II) corticosteroids

Suchergebnisse filtern